London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Ghia did you attend the AGM?
Thanks for the quick response Ghia and fair enough IMO. Closed forums are pretty public though.
Sounds as if your associate identified either Execs from big pharmaceutical companies or biotech investment funds / institutional funds. Either way no surprise really, especially the former given the potential for SNG001 to add to revenue streams and / or be a disrupter.
GLA
Thanks Ghia your comments make sense.
One advise: just do not reply / respond to Mani anymore. Not worth it.
Tommy seems a lot better to me. He gives good info. Mani is a ramper
Manifesto, to be fair the identity of a business person (or any person for that matter) attending a public AGM is not insider information.
Size82
Yes I agree, but the point here is that Ghia is implying he knows of something that is significant
but not sharing here... But more importantly he has made a point of saying that he
does not think it will have any relevance this year... Ever since Ghia reappeared in the
last few weeks he has been pushing the narrative that this is a "bottom drawer" stock
nothing significant will happen till 2023... On te day the deep dive resullts were released
many here were relieved to see strong positive data... Ghia posted
Such a shame the way this has worked out.
Science clearly worked but I get the feeling it’s too disruptive to the major pharma co drug pipelines.
Todays news is great but time lines here are not what they where. Bottom drawer investment worth holding onto but I don’t expect anything meaningful until 2023.
He knows that pre the SPRINTER results he was well respected here, IMHO he now
tries to use that to push his view that nothing will happen short term and shoots
down anyone who disagrees.... I really do not care if he attacks me, but turning
on Tommy is not being objective as he constantly reports himself to be on here..
He has also posted that he is taking "responsibility" for the content here.....
Really.... I think he has sold and looking to get back in under 20p just my view..
ATB!
Mani - The quickest way to get the share price below 20p is to ramp up news by end of August which fails to materialise.
Pi’s sucked in will panic the big boys will lap up the volatility and buy into the drop on the cheep.
If you want the price to drop you ramp the share up and create false hope. The history on this share shows exactly that missed deadlines imposed by Pi creating volatility in the share.
As for your accusations I have an opinion on timing here that you disagree with. When I voiced it many months ago it disagreed with your agenda and you took a dislike to it.
No amount of posts by the two of us will make the news and inflection points arrive sooner.
So don’t waste your heartbeats on it.
Now I have an actual genuine question to table to you or anyone who has taken the time to properly investigate Strive which I have not.
You claim it is due to start in August is there a specific meeting, webinar, date trigger point that will announce the trial. Or is this just a comment in an email from someone which is their best intentions but liable for slippage?
Hi Manifesto,
Re the points of Ghia's you posted. I don't think there is anything controversial in them.
1). "Such a shame the way this has worked out." Yes, obviously agree, but it ain't over yet.
2). "Science clearly worked but I get the feeling it’s too disruptive to the major pharma co drug pipelines. "
I disagree as whether it is disruptive or not will have no bearing on SNG001 getting to market. It will be disruptive when it's being used far and wide for some competitors, but it has to get to that point first.
3). "Todays news is great but time lines here are not what they where. Bottom drawer investment worth holding onto but I don’t expect anything meaningful until 2023".
Fair enough comment. As stated by the BoD at the AGM this is unlikely to be authorised for use in the next 12 months.
Ghia - Mani thinks you are trying to manipulate the sp to buy back in again having sold. Is she right? Lol
Ghia, our posts crossed. I think you answered the question...
Size82 - That’s the brush she is trying to tar me with.
Looking back through my posts you will see I reduced my holding after the poly TR1 the reasoning I gave was to take advantage of increased volatility.
I was uncertain what effect the Ukraine issues would have on the wider market and obviously we where in a state of flux here.
That move paid of well on a few of my other holdings which Vi’s fairly aggressively on the Ukraine situation.
Here we dropped and I made back a few shares but it was not anything to write home about.
I know a few investors that tried to play a swing trade here but they have since stopped because the trading range is too small to make it profitable.
In short I have more shares now than just after the P3 news and not looking to buy or sell any this year.
Size82
I did not imply there was anything controversial in his Post that I quoted.. The point
I was making is that he thinks it is a "bottom drawer" stock ... Ask yourself
this.... Why then does Ghia post here so frequently if he believes nothing
of relevance will happen till 2023... He says he believes his holding is in the
"upper quartile" for a PI... so presumably if he is wrong and big news lands
he is not going to miss out... He did disappear from here for months
so why is he suddenly an avid poster again now.... Well I think he knows
ACTIV2 are not far off...RNS confirms expected in the "Summer"... A
new trial could be announced anytime, Peer Review anytime...
A fair explanation is that he sold after SPRINTER as it was reasonable
to assume nothing much would happen for several months.. Now
he wants back in..... Surely you do not really expect him to admit it do you???
Ghia, I know I can see the accusations. Thanks for clarifying / explaining in detail for Manifesto and anyone else concerned.
Good luck with your investment. Same goes to all.
For whats its worth I don't see how anyone rational could think they could influence the sp with their posting on a board like this. To think otherwise would require a fair amount of hubris!
Have a good evening all and enjoy the sun if you're in blighty.